AMINA Bank AG, a global crypto bank licensed in Switzerland, reports a record financial performance for 2024 including a 69% surge in revenue to USD $40.4 million and a remarkable 136% increase in ...

Hedera Dx, the European techbio company headquartered in Switzerland, just announced the closing of a €15 million Series A financing round to drive advanced cancer care. The funding will fuel Hedera ...

GlycoEra AG, a biotechnology company pioneering best-in-class extracellular protein degraders for the treatment of autoimmune diseases, closed an oversubscribed $130 million Series B financing. The ...

The U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance for LEM Surgical’s Dynamis Robotic Surgical System, ...

Two global companies want to lead the way in tackling climate change using Swiss technologies and brainpower. Daphne Technology signed a licensing agreement with Saudi Aramco Technologies Company to ...

VRM Switzerland, provider of virtual reality simulators for helicopters, announces the completion of its latest CHF 9 million funding round with a group of private investors. The proceeds will ...

With market share of over 20% in important markets, Stromer has become a leading manufacturer of premium speed pedelecs. Under the ownership of Naxicap Partners, a France-based private equity firm, ...

Join us for an engaging webinar hosted by SHS partner addvantedge. This workshop dives into one of the most critical (and often misunderstood) challenges for startups: building an investment strategy ...

Yves Kilchenmann, CEO Nau media AG: «Für uns ist das ein erster Schritt in Richtung Print und zugleich die Tür zu zwei neuen Entwicklungsfeldern: dem Printprodukt selbst und der Distribution direkt in ...

Wecheer is revolutionizing the consumer-packaged goods (CPG) sector with its end-to-end trade management platform that was designed to help CPG brands manage their third-party distribution networks ...

At the heart of InVirtuoLabs' innovation is the Next Generation Virtual Lab, a proprietary platform that uses AI and molecular modeling to identify and optimize drugs with proven precision. This ...

PreComb, specializing in 3D tumor modeling for precision oncology, closed its Series A fundraising round. Precomb’s platform accelerates drug discovery and provides personalized therapies tailored to ...